French federation names Lajoux president
This article was originally published in Scrip
Executive Summary
Christian Lajoux, president of the French pharmaceutical industry associationLeem, has been elected president of the French federation of healthcare industries Féfis. Mr Lajoux, who is chairman of Sanofi-Aventis France, succeeds Jean-Pierre Cassan. The federation's 10 members represent around 900 companies that design, manufacture or market medicines and medical devices for both humans and animals. On his election, Mr Lajoux said he would work to reinforce the attractiveness and competitiveness of France in the life sciences sector.
You may also be interested in...
Cervarix link to UK girl's death "unlikely"
Local health authorities in Coventry, UK, say it is most unlikely that vaccination with GlaxoSmithKline's Cervarix (human papillomavirus vaccine) was the cause of the death of a 14-year-old schoolgirl on September 28th.
Generic Topamax launched in European markets
Patents on Janssen-Cilag's (Johnson & Johnson) anti-epileptic Topamax/Epitomax (topiramate) expired in many European countries on September 25th, and generics companies are launching their own versions quickly.
NICE confirms limits on Alimta for lung cancer
Lilly's Alimta (pemetrexed) has been recommended as a first-line treatment for some patients in England and Wales with non-small cell lung cancer (NSCLC) in binding guidance for the national health service.